Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Jan;9(1):508-510.
doi: 10.1016/j.jaip.2020.11.042. Epub 2020 Nov 30.

COVID-19 affecting hereditary angioedema patients with and without C1 inhibitor deficiency

Affiliations

COVID-19 affecting hereditary angioedema patients with and without C1 inhibitor deficiency

Anete S Grumach et al. J Allergy Clin Immunol Pract. 2021 Jan.
No abstract available

PubMed Disclaimer

References

    1. Avila J., Long B., Holladay D., Gottlieb M. Thrombotic complications of COVID-19. Am J Emerg Med. 2021;39:213–218. - PMC - PubMed
    1. de Nooijer A.H., Grondman I., Janssen N.A.F., Netea M.G., Willems L., van de Veerdonk F.L. Complement activation in the disease course of COVID-19 and its effects on clinical outcomes [published online ahead of print October 10, 2020] J Infect Dis. - DOI - PMC - PubMed
    1. Kanani A.S. A case report of COVID-19 virus infection in a patient with hereditary angioedema. 2020. https://assets.researchsquare.com/files/rs-41261/v1/22000e54-277d-4380-9... Available from:
    1. Azmy V., Benson J., Love K., Steele R. Idiopathic nonhistaminergic acquired angioedema in a patient with coronavirus disease 2019. Ann Allergy Asthma Immunol. 2020;125:600–602. - PMC - PubMed
    1. Polycarpou A., Howard M., Farrar C.A., Greenlaw R., Fanelli G., Wallis R. Rationale for targeting complement in COVID-19. EMBO Mol Med. 2020;12:e12642. - PMC - PubMed

Substances